📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

BRN2 is a non-canonical melanoma tumor-suppressor. (2021)

First Author: Hamm M

Attributed to: New signaling mechanisms in myelination funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41467-021-23973-5

PubMed Identifier: 34140478

Publication URI: http://europepmc.org/abstract/MED/34140478

Type: Journal Article/Review

Volume: 12

Parent Publication: Nature communications

Issue: 1

ISSN: 2041-1723